Growing community of inventors

Fränkisch-Crumbach, Germany

Claus Fittschen

Average Co-Inventor Count = 4.84

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 32

Claus FittschenPeter Raddatz (3 patents)Claus FittschenMatthias Wiesner (3 patents)Claus FittschenJoachim Gante (2 patents)Claus FittschenHanns Wurziger (2 patents)Claus FittschenSimon Lawrence Goodman (2 patents)Claus FittschenGuido Melzer (2 patents)Claus FittschenSabine Bernotat-Danielowski (2 patents)Claus FittschenHorst Juraszyk (2 patents)Claus FittschenDieter Dorsch (1 patent)Claus FittschenOliver Schadt (1 patent)Claus FittschenGunter Holzemann (1 patent)Claus FittschenMatthias Grell (1 patent)Claus FittschenJoachim März (1 patent)Claus FittschenClaus Fittschen (5 patents)Peter RaddatzPeter Raddatz (25 patents)Matthias WiesnerMatthias Wiesner (17 patents)Joachim GanteJoachim Gante (38 patents)Hanns WurzigerHanns Wurziger (38 patents)Simon Lawrence GoodmanSimon Lawrence Goodman (27 patents)Guido MelzerGuido Melzer (21 patents)Sabine Bernotat-DanielowskiSabine Bernotat-Danielowski (19 patents)Horst JuraszykHorst Juraszyk (18 patents)Dieter DorschDieter Dorsch (146 patents)Oliver SchadtOliver Schadt (58 patents)Gunter HolzemannGunter Holzemann (13 patents)Matthias GrellMatthias Grell (9 patents)Joachim MärzJoachim März (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merck Patent Gmbh (2 from 2,938 patents)

2. Merck Patent Gesellschaft MIT Beschrankter Haftung (2 from 1,248 patents)

3. Merck Kgaa (1 from 28 patents)


5 patents:

1. 8158799 - Hydroxyquinoline derivatives

2. 6849646 - Chromenone and chromanone derivatives as integrin inhibitors

3. 6602876 - Adhesion receptor antagonists

4. 6333308 - Cyclic peptide derivatives

5. 6204280 - Adhesion receptor antagonists

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/9/2025
Loading…